Press release: The authorization to use China’s Sinopharm vaccine

On 04 February 2021, the Ministry of Health issued a press release informing the authorization on the emergency use of China’s vaccine named “Sinopharm”. Sinopharm vaccine is manufactured by the Beijing Institute of Biological Products Co., Ltd. of the People’s Republic of China, under the condition of the Emergency Use Authorisation. 

Ministry of Health

Download: pdf